Literature DB >> 21887801

N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.

Christian Markl1, William P Clafshenkel, Mohamed I Attia, Shalini Sethi, Paula A Witt-Enderby, Darius P Zlotos.   

Abstract

A series of melatonin analogs obtained by the replacement of the ether methyl group with larger arylalkyl and aryloxyalkyl substituents was prepared in order to probe the melatonin receptors for MT(1) -selectivity. The most MT(1) -selective agents 11 and 15 were substituted with a Ph(CH(2) )(3) or a PhO(CH(2) )(3) group. Compounds 11 and 15 displayed 11.5-fold and 11-fold higher affinity for the MT(1) receptors than for the MT(2) subtype. Interestingly, in our binding assay 11 and 15 have shown considerably higher MT(1) -affinity and selectivity than the reference ligand, the dimeric agomelatine 1a.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21887801     DOI: 10.1002/ardp.201100125

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  7 in total

Review 1.  Update on melatonin receptors: IUPHAR Review 20.

Authors:  Ralf Jockers; Philippe Delagrange; Margarita L Dubocovich; Regina P Markus; Nicolas Renault; Gianluca Tosini; Erika Cecon; Darius P Zlotos
Journal:  Br J Pharmacol       Date:  2016-08-08       Impact factor: 8.739

Review 2.  Melatonergic drugs in development.

Authors:  Alessia Carocci; Alessia Catalano; Maria Stefania Sinicropi
Journal:  Clin Pharmacol       Date:  2014-09-18

3.  Synthesis, Spectroscopic Characterization and Antimicrobial Potential of Certain New Isatin-Indole Molecular Hybrids.

Authors:  Reem I Al-Wabli; Azza S Zakaria; Mohamed I Attia
Journal:  Molecules       Date:  2017-11-15       Impact factor: 4.411

4.  Antiproliferative activity and possible mechanism of action of certain 5-methoxyindole tethered C-5 functionalized isatins.

Authors:  Maha S Almutairi; Eman S Hassan; Adam B Keeton; Gary A Piazza; Ali S Abdelhameed; Mohamed I Attia
Journal:  Drug Des Devel Ther       Date:  2019-08-27       Impact factor: 4.162

5.  New radioligands for describing the molecular pharmacology of MT1 and MT2 melatonin receptors.

Authors:  Céline Legros; Ulrich Matthey; Teresa Grelak; Sandrine Pedragona-Moreau; Werner Hassler; Saïd Yous; Emmanuel Thomas; Franck Suzenet; Benoît Folleas; François Lefoulon; Pascal Berthelot; Daniel-Henri Caignard; Gérald Guillaumet; Philippe Delagrange; Jean-Louis Brayer; Olivier Nosjean; Jean A Boutin
Journal:  Int J Mol Sci       Date:  2013-04-25       Impact factor: 5.923

6.  Synthesis and characterization of new bivalent agents as melatonin- and histamine H3-ligands.

Authors:  Daniele Pala; Laura Scalvini; Alessio Lodola; Marco Mor; Lisa Flammini; Elisabetta Barocelli; Valeria Lucini; Francesco Scaglione; Silvia Bartolucci; Annalida Bedini; Silvia Rivara; Gilberto Spadoni
Journal:  Int J Mol Sci       Date:  2014-09-12       Impact factor: 5.923

7.  Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells.

Authors:  Giuliana Gatti; Valeria Lucini; Silvana Dugnani; Angela Calastretti; Gilberto Spadoni; Annalida Bedini; Silvia Rivara; Marco Mor; Gianfranco Canti; Francesco Scaglione; Annamaria Bevilacqua
Journal:  Oncotarget       Date:  2017-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.